Begin main content

Drug Reimbursement Recommendation — CDR — Fibristal

July 30, 2019
Today, CADTH has issued a recommendation for: ulipristal acetate (Fibristal) Indications: Uterine fibroids (signs and symptoms) Recommendation: Reimburse with clinical criteria and/or conditions For more information

Call for Patient Input and Clinical Experts: Stelara

July 12, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name ustekinumab Generic name Stelara Manufacturer Janssen Inc. Indication(s) Ulcerative colitis Project Number SR0627-000 Call for patient input 2019-07-12 Patient input deadline 2...

New at CADTH - July 2019

July 10, 2019
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

New Committee Brings Diverse Patient, Family, and Caregiver Voices to CADTH

July 10, 2019
Ottawa, ON (July 10, 2019) — Following a nationwide call for nominations, CADTH is pleased to announce the membership of its new Patient and Community Advisory Committee. Twelve individuals from across the country have been invited to join the committee as inaugural members. Committee members are patients or family caregivers and reflect the di...